RecruitingFemale onlyEN originalBreast cancer

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to learn more about the effects of your BRCA mutation on the ovaries. The BRCA gene can make it hard to conceive a child in the future. It may also bring on early menopause. The researchers will check blood levels of hormones that the ovaries produce. The hormones that researchers will check are anti-Mullerian hormone (AMH), estradiol and follicle stimulating hormone (FSH). The researchers will do this before, during, and after cancer treatment. The researchers will also ask you to fill out questionnaires about your menstrual cycle (your periods) and information about your health and pregnancies. This may help us learn which women will be more likely to have early menopause.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek 18-45 lat (dla kobiet z rakiem piersi) lub 25-45 lat (dla kobiet z mutacją BRCA)
  • •Kobieta przed menopauzą
  • •Regularne miesiączki (cykl 21-35 dni)
  • •Rozpoznany rak piersi stadium 0-III (dla grupy I) lub potwierdzona mutacja BRCA (dla grupy II)
  • •Planowana chemioterapia lub hormonoterapia (dla grupy I)
  • •Co najmniej 10 naturalnych cykli miesiączkowych w ciągu ostatniego roku
  • •Bez wcześniejszych zabiegów na jajnikach
  • •Bez wcześniejszej chemioterapii

✗ Disqualifies

  • •Brak regularnych miesiączek
  • •Więcej niż jeden nieregularny cykl miesiączkowy w ciągu ostatniego roku (z wyjątkami dla kobiet w ciąży)
  • •Wcześniejsza chemioterapia
  • •Wcześniejsza operacja lub choroba jajników
  • •PCOS (zespół policystycznych jajników)
  • •Hormonalna antykoncepcja w ciągu ostatnich 4 tygodni

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
44 Years
Last updated (source)
October 16, 2026
Sex
Female only

Therapies / drugs in trial

Locations (8)

Memorial Sloan Kettering Basking Ridge

Basking Ridge, United States

Memorial Sloan Kettering Monmouth

Middletown, United States

Memorial Sloan Kettering Bergen

Montvale, United States

Memorial Sloan Kettering Commack

Commack, United States

Memorial Sloan Kettering Westchester

Harrison, United States

Memorial Sloan Kettering Cancer Center

New York, United States

New York Presbyterian Hospital-Weill Medical College of Cornell University

New York, United States

Memorial Sloan Kettering Nassau

Uniondale, United States

Trial contact

Shari Goldfarb, MD

Minna Lee, MD

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/17/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.